Global Genomics Combined Artificial Intelligence Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI07252479

Publication Date:

July 2, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Genomics Combined Artificial Intelligence market size is predicted to grow from US$ 799 million in 2025 to US$ 1499 million in 2031; it is expected to grow at a CAGR of 11.1% from 2025 to 2031.
The companies of Genomics Combined Artificial Intelligence use deep learning to mine vast amounts of genetic information for new clues about disease, diagnosis or treatment and combine the amazing potential in AI and genetics for opening new horizons in healthcare.
Market Overview:
The combination of AI and genomics has transformed the healthcare, pharmaceutical, and biotech sectors. Rapid advances in genome sequencing technologies, coupled with AI-driven data analytics, are revolutionizing drug discovery, disease diagnostics, and precision medicine.
Key Market Trends:
Adoption of machine learning (ML) and deep learning (DL) algorithms for genomic data interpretation. Expansion of direct-to-consumer (DTC) genomic testing combined with AI for ancestry and health risk assessment. Increasing collaborations between pharmaceutical giants and AI-driven biotech startups. AI-driven genome editing tools such as CRISPR optimization.
Market Regional Analysis:
The United States leads in research, investment, and AI-driven genomics startups. Strong regulatory frameworks and government initiatives such as NIH funding and AI-driven health policies have fueled growth. Europe is increasingly focusing on precision medicine and AI-based genomic research, supported by regulatory agencies such as the European Health Data Space (EHDS). Asia Pacific is the fastest-growing market, led by China, Japan, and India. China鈥檚 government-backed AI and genomics initiatives and significant private sector investment have fueled rapid expansion.
Market Development Opportunities and Risks:
AI-driven genomics enhances treatment plans for patients and improves clinical outcomes. AI-driven drug discovery reduces the time and cost required to develop new drugs. Advances in AI-driven genome editing improve the precision of CRISPR-based gene therapies. Integration with cloud computing facilitates large-scale genomic data analysis and AI model training. The growth of telemedicine and DTC genetic testing expands consumers' access to genomic insights. AI-driven genomic analysis requires large data sets, posing safety and ethical challenges. Global regulation of genetic data use and AI-driven diagnostics varies. High cost and complexity: Despite cost reductions, AI-driven genomic solutions remain expensive in some regions. AI models trained on biased data sets may produce inaccurate genomic interpretations.
The 鈥淕enomics Combined Artificial Intelligence Industry Forecast鈥� looks at past sales and reviews total world Genomics Combined Artificial Intelligence sales in 2024, providing a comprehensive analysis by region and market sector of projected Genomics Combined Artificial Intelligence sales for 2025 through 2031. With Genomics Combined Artificial Intelligence sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genomics Combined Artificial Intelligence industry.
This Insight Report provides a comprehensive analysis of the global Genomics Combined Artificial Intelligence landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genomics Combined Artificial Intelligence portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Genomics Combined Artificial Intelligence market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genomics Combined Artificial Intelligence and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genomics Combined Artificial Intelligence.
This report presents a comprehensive overview, market shares, and growth opportunities of Genomics Combined Artificial Intelligence market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pharmaco Genomics
Personal Genomics
Segmentation by Application:
Hereditary Disease Genetic Testing
Cancer Genetic Testing
Ancestry & Traits Genetic Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Deep Genomics
Verge Genomics
Verily Life Sciences
DeCODE
GenBio AI
Insilico Medicine
Tempus
Insitro
Immunai

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genomics Combined Artificial Intelligence Market Size (2020-2031)
2.1.2 Genomics Combined Artificial Intelligence Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Genomics Combined Artificial Intelligence by Country/Region (2020, 2024 & 2031)
2.2 Genomics Combined Artificial Intelligence Segment by Type
2.2.1 Pharmaco Genomics
2.2.2 Personal Genomics
2.3 Genomics Combined Artificial Intelligence Market Size by Type
2.3.1 Genomics Combined Artificial Intelligence Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Genomics Combined Artificial Intelligence Market Size Market Share by Type (2020-2025)
2.4 Genomics Combined Artificial Intelligence Segment by Application
2.4.1 Hereditary Disease Genetic Testing
2.4.2 Cancer Genetic Testing
2.4.3 Ancestry & Traits Genetic Testing
2.4.4 Others
2.5 Genomics Combined Artificial Intelligence Market Size by Application
2.5.1 Genomics Combined Artificial Intelligence Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Genomics Combined Artificial Intelligence Market Size Market Share by Application (2020-2025)
3 Genomics Combined Artificial Intelligence Market Size by Player
3.1 Genomics Combined Artificial Intelligence Market Size Market Share by Player
3.1.1 Global Genomics Combined Artificial Intelligence Revenue by Player (2020-2025)
3.1.2 Global Genomics Combined Artificial Intelligence Revenue Market Share by Player (2020-2025)
3.2 Global Genomics Combined Artificial Intelligence Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genomics Combined Artificial Intelligence by Region
4.1 Genomics Combined Artificial Intelligence Market Size by Region (2020-2025)
4.2 Global Genomics Combined Artificial Intelligence Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genomics Combined Artificial Intelligence Market Size Growth (2020-2025)
4.4 APAC Genomics Combined Artificial Intelligence Market Size Growth (2020-2025)
4.5 Europe Genomics Combined Artificial Intelligence Market Size Growth (2020-2025)
4.6 Middle East & Africa Genomics Combined Artificial Intelligence Market Size Growth (2020-2025)
5 Americas
5.1 Americas Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
5.2 Americas Genomics Combined Artificial Intelligence Market Size by Type (2020-2025)
5.3 Americas Genomics Combined Artificial Intelligence Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genomics Combined Artificial Intelligence Market Size by Region (2020-2025)
6.2 APAC Genomics Combined Artificial Intelligence Market Size by Type (2020-2025)
6.3 APAC Genomics Combined Artificial Intelligence Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genomics Combined Artificial Intelligence Market Size by Country (2020-2025)
7.2 Europe Genomics Combined Artificial Intelligence Market Size by Type (2020-2025)
7.3 Europe Genomics Combined Artificial Intelligence Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genomics Combined Artificial Intelligence by Region (2020-2025)
8.2 Middle East & Africa Genomics Combined Artificial Intelligence Market Size by Type (2020-2025)
8.3 Middle East & Africa Genomics Combined Artificial Intelligence Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genomics Combined Artificial Intelligence Market Forecast
10.1 Global Genomics Combined Artificial Intelligence Forecast by Region (2026-2031)
10.1.1 Global Genomics Combined Artificial Intelligence Forecast by Region (2026-2031)
10.1.2 Americas Genomics Combined Artificial Intelligence Forecast
10.1.3 APAC Genomics Combined Artificial Intelligence Forecast
10.1.4 Europe Genomics Combined Artificial Intelligence Forecast
10.1.5 Middle East & Africa Genomics Combined Artificial Intelligence Forecast
10.2 Americas Genomics Combined Artificial Intelligence Forecast by Country (2026-2031)
10.2.1 United States Market Genomics Combined Artificial Intelligence Forecast
10.2.2 Canada Market Genomics Combined Artificial Intelligence Forecast
10.2.3 Mexico Market Genomics Combined Artificial Intelligence Forecast
10.2.4 Brazil Market Genomics Combined Artificial Intelligence Forecast
10.3 APAC Genomics Combined Artificial Intelligence Forecast by Region (2026-2031)
10.3.1 China Genomics Combined Artificial Intelligence Market Forecast
10.3.2 Japan Market Genomics Combined Artificial Intelligence Forecast
10.3.3 Korea Market Genomics Combined Artificial Intelligence Forecast
10.3.4 Southeast Asia Market Genomics Combined Artificial Intelligence Forecast
10.3.5 India Market Genomics Combined Artificial Intelligence Forecast
10.3.6 Australia Market Genomics Combined Artificial Intelligence Forecast
10.4 Europe Genomics Combined Artificial Intelligence Forecast by Country (2026-2031)
10.4.1 Germany Market Genomics Combined Artificial Intelligence Forecast
10.4.2 France Market Genomics Combined Artificial Intelligence Forecast
10.4.3 UK Market Genomics Combined Artificial Intelligence Forecast
10.4.4 Italy Market Genomics Combined Artificial Intelligence Forecast
10.4.5 Russia Market Genomics Combined Artificial Intelligence Forecast
10.5 Middle East & Africa Genomics Combined Artificial Intelligence Forecast by Region (2026-2031)
10.5.1 Egypt Market Genomics Combined Artificial Intelligence Forecast
10.5.2 South Africa Market Genomics Combined Artificial Intelligence Forecast
10.5.3 Israel Market Genomics Combined Artificial Intelligence Forecast
10.5.4 Turkey Market Genomics Combined Artificial Intelligence Forecast
10.6 Global Genomics Combined Artificial Intelligence Forecast by Type (2026-2031)
10.7 Global Genomics Combined Artificial Intelligence Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Genomics Combined Artificial Intelligence Forecast
11 Key Players Analysis
11.1 Deep Genomics
11.1.1 Deep Genomics Company Information
11.1.2 Deep Genomics Genomics Combined Artificial Intelligence Product Offered
11.1.3 Deep Genomics Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Deep Genomics Main Business Overview
11.1.5 Deep Genomics Latest Developments
11.2 Verge Genomics
11.2.1 Verge Genomics Company Information
11.2.2 Verge Genomics Genomics Combined Artificial Intelligence Product Offered
11.2.3 Verge Genomics Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Verge Genomics Main Business Overview
11.2.5 Verge Genomics Latest Developments
11.3 Verily Life Sciences
11.3.1 Verily Life Sciences Company Information
11.3.2 Verily Life Sciences Genomics Combined Artificial Intelligence Product Offered
11.3.3 Verily Life Sciences Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Verily Life Sciences Main Business Overview
11.3.5 Verily Life Sciences Latest Developments
11.4 DeCODE
11.4.1 DeCODE Company Information
11.4.2 DeCODE Genomics Combined Artificial Intelligence Product Offered
11.4.3 DeCODE Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 DeCODE Main Business Overview
11.4.5 DeCODE Latest Developments
11.5 GenBio AI
11.5.1 GenBio AI Company Information
11.5.2 GenBio AI Genomics Combined Artificial Intelligence Product Offered
11.5.3 GenBio AI Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 GenBio AI Main Business Overview
11.5.5 GenBio AI Latest Developments
11.6 Insilico Medicine
11.6.1 Insilico Medicine Company Information
11.6.2 Insilico Medicine Genomics Combined Artificial Intelligence Product Offered
11.6.3 Insilico Medicine Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Insilico Medicine Main Business Overview
11.6.5 Insilico Medicine Latest Developments
11.7 Tempus
11.7.1 Tempus Company Information
11.7.2 Tempus Genomics Combined Artificial Intelligence Product Offered
11.7.3 Tempus Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Tempus Main Business Overview
11.7.5 Tempus Latest Developments
11.8 Insitro
11.8.1 Insitro Company Information
11.8.2 Insitro Genomics Combined Artificial Intelligence Product Offered
11.8.3 Insitro Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Insitro Main Business Overview
11.8.5 Insitro Latest Developments
11.9 Immunai
11.9.1 Immunai Company Information
11.9.2 Immunai Genomics Combined Artificial Intelligence Product Offered
11.9.3 Immunai Genomics Combined Artificial Intelligence Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Immunai Main Business Overview
11.9.5 Immunai Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂